# Dexased™ and Dexmedvet™ recall: Dexmedetomidine Hydrochloride Injection 0.5 mg/mL

> 24 April 2025: US FDA published a recall of Dexmedetomidine Hydrochloride Injection 0.5 mg/mL (Dexased™ and Dexmedvet™). Reason: Presence of particulate…

- Source page: https://pawmultiverse.com/r/us/us-fda-animal-recalls/2025-04-24-49496fdb/
- Official notice: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cronus-pharma-llc-initiating-voluntary-recall-dexasedtm-aspen-and-dexmedvettm-cronus-pharma-llc
- Authority: US FDA
- Country: United States
- Announced: 2025-04-24
- Brand: Dexased™ and Dexmedvet™
- Company: Cronus Pharma LLC
- Product: Dexmedetomidine Hydrochloride Injection 0.5 mg/mL
- Reason: Presence of particulate matter
- Lot codes: C24041AV1, C24041AV2
- Record status: listed

## Questions

### Which Dexased™ and Dexmedvet™ products are recalled?

Dexmedetomidine Hydrochloride Injection 0.5 mg/mL, sold under Dexased™ and Dexmedvet™. Lot or batch codes: C24041AV1, C24041AV2. Best before: Oct 2026.

### Why was it recalled?

Presence of particulate matter.

### What should I do if I have it?

Stop feeding it and keep it away from pets and children. Keep the packaging and the receipt. If your pet has eaten it and seems unwell, call your vet. Most shops refund or replace recalled pet food.

### Is this recall still active?

Yes. US FDA still lists it (checked 27 October 2026).

### Where is the official notice?

On the US FDA website: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/cronus-pharma-llc-initiating-voluntary-recall-dexasedtm-aspen-and-dexmedvettm-cronus-pharma-llc

## In English, briefly (AI-written)

Cronus Pharma LLC is recalling Dexased and Dexmedvet Dexmedetomidine Hydrochloride Injection 0.5 mg/mL due to the presence of particulate matter. The recall of Dexased and Dexmedvet was announced on April 24, 2025.

## Licence

Paw Multiverse recall record, CC BY 4.0. Cite: https://pawmultiverse.com/r/us/us-fda-animal-recalls/2025-04-24-49496fdb/. This is what an authority published, not advice.
